The 2026 WHO dementia guideline recommends managing cholesterol along with blood pressure and diabetes to protect brain health. For adults over 65, tracking means keeping a dated record of lipid results, medicines, and clinician advice without judging the numbers alone. Dyslipidemia is the medical term for unhealthy cholesterol levels. The guideline treats it as one modifiable factor among several, not a home diagnosis.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the official guidance from Who — Use this primary source to verify the official guidance.
- Read the official guidance from Who — Use this primary source to verify the official guidance.
Table of Contents
- Why cholesterol appears in the guideline
- What a lipid panel reports
- How often to recheck after 65
- How to track without self-diagnosing
Why cholesterol appears in the guideline
The World Health Organization names high cholesterol and dyslipidemia alongside hypertension, diabetes, smoking, inactivity, hearing loss, social isolation, and air pollution as modifiable factors the WHO publication page. It recommends managing blood pressure, diabetes, and cholesterol to protect brain health. The Cambridge Public Health summary of the 2024 Lancet Commission lists high LDL cholesterol from around age 40 as a dementia risk factor.
It estimates 7% of dementia cases link to high LDL and another 2% to untreated later-life vision loss. Midlife levels matter because exposure builds over years. After 65, control still matters as part of vascular and brain health, guided by a clinician.
What a lipid panel reports
Yale Medicine describes a lipid-panel blood test that reports total cholesterol, LDL, HDL, and triglycerides in mg/dL the Yale Medicine explainer. Adults can ask primary care for this test rather than using home estimates.
The CDC lists reference levels for adults at about 150 mg/dL total cholesterol, about 100 mg/dL LDL, and under 150 mg/dL triglycerides CDC reference levels. It lists at least 40 mg/dL HDL in men and 50 mg/dL in women, with results interpreted by a clinician in context.
How often to recheck after 65
CDC guidance summarized in 2026 advises repeat screening every 4 to 6 years for most healthy adults. People with heart disease, diabetes, or family history of high cholesterol need more frequent testing, so older adults follow clinician-set intervals.
The March 2026 ACC and AHA-led dyslipidemia update sets different LDL goals by risk. Goals fall below 100 mg/dL for low-to-intermediate risk and below 70 mg/dL for high risk. For very-high-risk secondary prevention, the goal falls below 55 mg/dL, set after clinician-patient discussion and PREVENT estimation for ages 30 to 79.
How to track without self-diagnosing
Tracking works when the log is complete and interpretation stays with the clinician. Bring the record to each visit and ask what changed, why it matters, and what to do next.
Medical News Today, reporting on the WHO second edition, notes the 45% and 7% figures are population estimates from largely observational data, not personal guarantees Medical News Today reporting on the WHO second edition. It also notes cholesterol drugs have not been proven in randomized trials with dementia as the main endpoint, so changes need medical supervision.
- Test date, lab name, and reason for the test
- Total cholesterol, LDL, HDL, and triglycerides with units
- Cholesterol and related medicines, doses, and recent changes
- Clinician advice, target range given, and next test date
You Might Also Like
- Hearing Aids in the 2026 WHO Dementia Guideline: What Adults Over 65 Can Track Without Self-Diagnosing
- Diabetes in the 2026 WHO Dementia Guideline: What Adults Over 65 Can Track Without Self-Diagnosing
- Blood Pressure in the 2026 WHO Dementia Guideline: What Adults Over 65 Can Track Without Self-Diagnosing
